Download ICD-9-CM/ICD-10-CM Crosswalk for Adult Male

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Discovery and development of antiandrogens wikipedia , lookup

Androgen insensitivity syndrome wikipedia , lookup

Transcript
ICD-9-CM/ICD-10-CM Crosswalk for Adult Male Reproductive Disorders
2015
ICD-9-CM
253.4 Other anterior pituitary disorders
(isolated or partial deficiency of an anterior
pituitary hormone, other than growth
hormone)
253.7 Hypopituitarism, iatrogenic--also code
cause (use additional E code to identify
cause)
257.0 Testicular hyperfunction
(hypersecretion of testicular hormones)
257.1 Postablative testicular hypofunction
Testicular hypofunction: iatrogenic,
postirradiation, postsurgical
257.2 Other testicular hypofunction
(defective synthesis of testicular androgen,
eunuchoidism [NOS, hypogonadotropic],
failure [Leydig’s cells, adult; seminiferous
tubule, adult], testicular hypogonadism
257.8 Other testicular dysfunction
257.9 Unspecified testicular dysfunction
259.5 Androgen insensitivity syndrome (aka
testicular feminization)
275.0 Disorders of iron metabolism (e.g.
Hemochromatosis)
289.0 Polycythemia, secondary
302.50 Trans-sexualism, unspecified sexual
history
302.72 Psychosexual dysfunction with
ICD-10-CM
E23.0 Hypopituitarism (Hypogonadotropic
hypogonadism, Isolated deficiency of
gonadotropin, Kallmann’s syndrome)
E23.1 Drug-induced hypopituitarism
E89.3 Postprocedural hypopituitarism
E29.0 Testicular hyperfunction
(hypersecretion of testicular hormones)
E89.5 Postprocedural testicular
hypofunction
E29.1 Testicular hypofunction (defective
synthesis of testicular androgen NOS, 5delta-reductase deficiency [with male
pseudohermaphroditism], testicular
hypogonadism NOS)
Use additional code for adverse effect, if
applicable, to identify drug (T36-T50 with 5th
or 6th character 5)
E29.8 Other testicular dysfunction
E29.9 Testicular dysfunction, unspecified
E34.50 Androgen insensitivity syndrome,
unspecified
E34.51 Complete androgen insensitivity
syndrome
E34.52 Partial androgen insensitivity
syndrome
E83.110 Hereditary hemochromatosis
E83.111 Hemochromatosis due to repeated
blood cell transfusions
E83.118 Other hemochromatosis
E83.119 Hemochromatosis, unspecified
E83.19 Other disorders of iron metabolism
D75.1 Secondary polycythemia
F64.1 Gender identity disorder in
adolescence and adulthood
Z87.890 Personal history of sex
reassignment
F52.21 Male erectile disorder (psychogenic
All information is subject to change. This is not an all-inclusive list.
inhibited sexual excitement (aka non-organic
or psychogenic erectile dysfunction)
302.74 Male orgasmic disorder
302.75 Premature ejaculation
456.4 Scrotal varices (varicocele)
600.00 Hypertrophy (benign) of prostate w/o
urinary obstruction and other lower urinary
tract symptoms (LUTS)
600.01 Hypertrophy (benign) of prostate
with urinary obstruction and other lower
urinary tract symptoms (LUTS)
600.10 Nodular prostate (hard, firm prostate;
multinodular prostate) without urinary
obstruction (
600.11 Nodular prostate with urinary
obstruction
601.0 Prostatitis, acute
601.1 Chronic prostatitis
601.9 Prostatitis unspecified
603.9 Hydrocele, unspecified
604.90 Orchitis and epididymitis, unspecified
impotence)
F52.32 Male orgasmic disorder
F52.4 Premature ejaculation
I86.1 Scrotal varices (varicocele)
N40.0 Enlarged prostate w/o lower urinary
tract symptoms (enlarged prostate NOS,
enlarged prostate w/o LUTS)
N40.1 Enlarged prostate with lower urinary
tract symptoms (enlarged prostate with
LUTS)
Use additional code for associated
symptoms, when specified: incomplete
bladder emptying [R39.14], nocturia [R35.1],
straining on urination [R39.16], urinary
frequency [R35.0], urinary hesitancy
[R39.11], urinary incontinence [N39.4-],
urinary obstruction [N13.8], urinary retention
[R33.8], urinary urgency [R39.15], weak
urinary stream [R39.12]
N40.2 Nodular prostate without lower
urinary tract symptoms (nodular prostate
without LUTS)
N40.3 Nodular prostate with lower urinary
tract symptoms
Use additional code for associated
symptoms, when specified: incomplete
bladder emptying [R39.14], nocturia [R35.1],
straining on urination [R39.16], urinary
frequency [R35.0], urinary hesitancy
[R39.11], urinary incontinence [N39.4-],
urinary obstruction [N13.8], urinary retention
[R33.8], urinary urgency [R39.15], weak
urinary stream [R39.12]
N41.0 Acute prostatitis
N41.1 Chronic prostatitis
N41.9 Inflammatory disease of prostate,
unspecified (prostatitis NOS)
N43.0 Encysted hydrocele
N43.1 Infected hydrocele
N43.2 Other hydrocele
N43.3 Hydrocele, unspecified
N45.1 Epididymitis
All information is subject to change. This is not an all-inclusive list.
606.0 Infertility, male: Azoospermia
606.1 Infertility, male: Oligospermia
606.8 Infertility due to extratesticular causes
N/A
606.9 Infertility, male, unspecified
607.3 Priapism
607.84 Impotence, organic origin
(physiologic, not psychogenic)
N45.2 Orchitis
N45.3 Epididymo-orchitis
N46.01 Organic azoospermia
N46.021 Azoospermia due to drug therapy
N46.022 Azoospermia due to infection
N46.023 Azoospermia due to obstruction of
efferent ducts
N46.024 Azoospermia due to radiation
N46.025 Azoospermia due to systemic
disease
N46.029 Azoospermia due to other
extratesticular causes
N46.11 Organic oligospermia
N46.121 Oligospermia due to drug therapy
N46.122 Oligospermia due to infection
N46.123 Oligospermia due to obstruction of
efferent ducts
N46.124 Oligospermia due to radiation
N46.125 Oligospermia due to systemic
disease
N46.129 Oligospermia due to other
extratesticular causes
N46.8 Other male infertility
N46.9 Male infertility, unspecified
N48.30 Priapism, unspecified
N48.31 Priapism due to trauma
N48.32 Priapism due to disease classified
elsewhere
N48.33 Priapism, drug-induced
N48.39 Other priapism
N52.01 Erectile dysfunction due to arterial
insufficiency
N52.02 Corporo-venous occlusive erectile
dysfunction
N52.03 Combined arterial insufficiency and
corporo-venous occlusive erectile
dysfunction
N52.1 Erectile dysfunction due to diseases
classified elsewhere
N52.2 Drug-induced erectile dysfunction
N52.31 Erectile dysfunction following radical
prostatectomy
N52.32 Erectile dysfunction following radical
All information is subject to change. This is not an all-inclusive list.
607.85 Peyronie’s disease
608.1 Spermatocele
608.3 Atrophy of testis
608.86 Edema of male genital organs
(testicular swelling, mass, or lump)
cystectomy
N52.33 Erectile dysfunction following
urethral surgery
N52.34 Erectile dysfunction following simple
prostatectomy
N52.39 Other post-surgical erectile
dysfunction
N52.8 Other male erectile dysfunction
N52.9 Male erectile dysfunction, unspecified
N48.6 Induration penis plastica (Peyronie’s
disease, plastic induration of penis)
N43.40 Spermatocele of epididymis,
unspecified
N43.41 Spermatocele of epididymis, single
N43.42 Spermatocele of epididymis, multiple
N50.0 Atrophy of testis
N50.8 Other specified disorders of male
genital organs (edema/hypertrophy of
scrotum, seminal vesicles, spermatic cord,
testis, tunica vaginalis, and vas deferens,
OR
608.87 Retrograde ejaculation
608.89 Other specified disorders of male
genital organs
608.9 Unspecified disorder of male genital
organs
611.1 Gynecomastia
611.6 Galactorrhea not associated with
childbirth
611.71 Mastodynia (pain in breast)
611.72 Lump or mass in breast
611.79 Other disorders of breast (nipple
discharge)
752.51 Testis, undescended (cryptorchidism)
R22.9 Localized swelling, mass, and lump,
unspecified
N53.14 Retrograde ejaculation
N50.3 Cyst of epididymis
N50.9 Disorder of male genital organs,
unspecified
N62 Hypertrophy of breast
N64.3 Galactorrhea not associated with
childbirth
N64.4 Mastodynia
N63 Unspecified lump in breast
N64.52 Nipple discharge
Q53.00 Ectopic testis, unspecified
Q53.01 Ectopic testis, unilateral
Q53.02 Ectopic testes, bilateral
Q53.10 Unspecified undescended testicle,
unilateral
Q53.11 Abdominal testis, unilateral
All information is subject to change. This is not an all-inclusive list.
752.64 Micropenis
758.7 Klinefelter’s syndrome
780.57 Sleep apnea, unspecified
780.79 Fatigue & malaise, other
780.8 Hyperhidrosis, generalized
(diaphoresis, excessive sweating)
781.1 Disturbances of sensation of smell and
taste (anosmia)
782.62 Flushing
788.41 Urinary frequency
788.43 Nocturia
788.61 Splitting of urinary stream
(intermittent urinary stream)
788.62 Slowing of urinary stream (weak
stream)
788.63 Urgency of urination
788.64 Urinary hesitancy
788.65 Straining on urination
788.69 Other abnormality of urination
790.93 Elevated prostate specific antigen
(PSA)
792.2 Nonspecific abnormal findings in other
body substances: semen (abnormal
spermatozoa)
Q53.12 Ectopic perineal testis, unilateral
Q53.20 Undescended testicle, unspecified,
bilateral
Q53.21 Abdominal testis, bilateral
Q53.22 Ectopic perineal testis, bilateral
Q53.9 Undescended testicle, unspecified
Q55.62 Hypoplasia of penis
Q98.0 Klinefelter syndrome karyotype 47,
XXY
Q98.1 Klinefelter syndrome, male with more
than two X chromosomes
Q98.3 Other male with 46, XX karyotype
Q98.4 Klinefelter syndrome, unspecified
G47.30 Sleep apnea, unspecified
G93.3 Postviral fatigue syndrome
R53.0 Neoplastic (malignant) related fatigue
R53.1 Weakness
R53.81 Other malaise
R53.83 Other fatigue
R61 Generalized hyperhidrosis (excessive
sweating, night sweats)
R43.0 Anosmia
R23.2 Flushing
R35.0 Frequency of micturition
R35.1 Nocturia
R39.13 Splitting of urinary stream
(intermittent)
R39.12 Poor urinary stream (weak urinary
stream)
R39.15 Urgency of urination
R39.11 Hesitancy of micturition
R39.16 Straining to void
R39.14 Feeling of incomplete bladder
emptying
R39.19 Other difficulties with micturition
R97.2 Elevated prostate specific antigen
(PSA)
R86.0 Abnormal levels of enzymes in
specimens from male genital organs
R86.1 Abnormal levels of hormones in
specimens from male genital organs
R86.2 Abnormal level of other drugs,
All information is subject to change. This is not an all-inclusive list.
799.22 Irritability
799.24 Emotional lability
799.81 Decreased sexual desire NOS
N/A
962.1 Poisoning by hormones and synthetic
substitutes: androgens and anabolic
congeners
medicaments and biological substances in
specimens from male genital organs
R86.3 Abnormal levels of substances chiefly
nonmedicinal as to source in specimens from
male genital organs
R86.4 Abnormal immunological findings in
specimens from male genital organs
R86.5 Abnormal microbiological findings in
specimens from male genital organs
R86.6 Abnormal cytological findings in
specimens from male genital organs
R86.7 Abnormal histological findings in
specimens from male genital organs
R86.8 Other abnormal findings in specimens
from male genital organs (abnormal
chromosomal findings in specimens from
male genital organs)
R86.9 Unspecified abnormal finding in
specimens from male genital organs
R45.4 Irritability and anger
R45.86 Emotional lability
R68.62 Decreased libido
T38.6X1X Poisoning by antigonadotrophins,
antiestrogens, antiandrogens, not elsewhere
classified, accidental (unintentional) (X
depends on initial (A), subsequent (D), or
sequela (S) encounter)
T38.6X2X Poisoning by antigonadotrophins,
antiestrogens, antiandrogens, not elsewhere
classified, intentional self-harm (X depends
on initial (A), subsequent (D), or sequela (S)
encounter)
T38.6X3X Poisoning by antigonadotrophins,
antiestrogens, antiandrogens, not elsewhere
classified, assault (X depends on initial (A),
subsequent (D), or sequela (S) encounter)
T38.6X4X Poisoning by antigonadotrophins,
antiestrogens, antiandrogens, not elsewhere
classified, undetermined (X depends on initial
(A), subsequent (D), or sequela (S) encounter)
T38.7X1X Poisoning by androgens and
anabolic congeners, accidental
(unintentional) (X depends on initial (A),
All information is subject to change. This is not an all-inclusive list.
962.4 Poisoning by hormones and synthetic
substitutes: anterior pituitary hormones
(corticotropin, gonadotropin, somatotropin
[growth hormone])
E932.0 Adverse effects of adrenal cortical
steroids
N/A
E932.1 Adverse effects of androgens and
anabolic congeners
E932.4 Adverse effects of anterior pituitary
hormones (corticotropin, gonadotropin,
somatotropin [growth hormone])
subsequent (D), or sequela (S) encounter)
T38.7X2X Poisoning by androgens and
anabolic congeners, intentional self-harm (X
depends on initial (A), subsequent (D), or
sequela (S) encounter)
T38.7X3X Poisoning by androgens and
anabolic congeners, assault (X depends on
initial (A), subsequent (D), or sequela (S)
encounter)
T38.7X4X Poisoning by androgens and
anabolic congeners, undetermined (X
depends on initial (A), subsequent (D), or
sequela (S) encounter)
T38.811X Poisoning by anterior pituitary
hormones (unintentional) (X depends on
initial (A), subsequent (D), or sequela (S)
encounter)
T38.812X Poisoning by anterior pituitary
hormones, intentional self-harm (X depends
on initial (A), subsequent (D), or sequela (S)
encounter)
T38.813X Poisoning by anterior pituitary
hormones, assault (X depends on initial (A),
subsequent (D), or sequela (S) encounter)
T38.814X Poisoning by anterior pituitary
hormones, undetermined (X depends on
initial (A), subsequent (D), or sequela (S)
encounter)
T38.0X5X Adverse effect of glucocorticoids
and synthetic analogues (X depends on initial
(A), subsequent (D), or sequela (S) encounter)
T38.6X5X Adverse effect of
antigonadotrophins, antiestrogens,
antiandrogens, not elsewhere classified,
undetermined (X depends on initial (A),
subsequent (D), or sequela (S) encounter)
T38.7X5X Adverse effect of androgens and
anabolic congeners (X depends on initial (A),
subsequent (D), or sequela (S) encounter)
T38.815X Adverse effect of anterior pituitary
[adenohypophyseal] hormones (X depends
on initial (A), subsequent (D), or sequela (S)
encounter)
All information is subject to change. This is not an all-inclusive list.
E935.2 Adverse effects of other opiates and
related narcotics (codeine, morphine, opium
[alkaloids], meperidine [pethidine])
N/A
N/A
N/A
V07.51 Long-term (current) drug use:
selective estrogen receptor modulators
(SERMs)
V10.3 Personal history of malignant neoplasm
of breast
Personal history of malignant neoplasm of
male genital organ:
V10.45 Unspecified
V10. 46 Prostate
V10.47 Testis
V10.48 Epididymis
V10.49 Other male genital organs
V12.29 Personal history of other endocrine,
metabolic and immunity disorders
V12.51 Personal history of diseases of
circulatory system: venous thrombosis and
T40.0X5X Adverse effect of opium (X
depends on initial (A), subsequent (D), or
sequela (S) encounter)
T40.2X5X Adverse effect of other opioids (X
depends on initial (A), subsequent (D), or
sequela (S) encounter)
T40.4X5X Adverse effect of other synthetic
narcotics (X depends on initial (A),
subsequent (D), or sequela (S) encounter)
T40.605X Adverse effect of unspecified
narcotics (X depends on initial (A),
subsequent (D), or sequela (S) encounter)
T40.695X Adverse effect of other narcotics (X
depends on initial (A), subsequent (D), or
sequela (S) encounter)
T38.6X6X Underdosing of
antigonadotrophins, antiestrogens,
antiandrogens, not elsewhere classified (X
depends on initial (A), subsequent (D), or
sequela (S) encounter)
T38.7X6X Underdosing of androgens and
anabolic congeners (X depends on initial (A),
subsequent (D), or sequela (S) encounter)
T38.816X Underdosing of anterior pituitary
[adenohypophyseal] hormones (X depends
on initial (A), subsequent (D), or sequela (S)
encounter)
Z79.810 Long-term (current) use of selective
estrogen receptor modulators (SERMs)
Z85.3 Personal history of malignant
neoplasm of breast
Personal history of malignant neoplasm of
male genital organ:
Z85.45 Unspecified
Z85.46 Prostate
Z85.47 Testis
Z85.48 Epididymis
Z85.49 Other male genital organs
Z86.39 Personal history of other endocrine
nutritional and metabolic diseases
Z86.718 Personal history of other venous
thrombosis and embolism
All information is subject to change. This is not an all-inclusive list.
embolism
Family history of malignant neoplasm of
genital organs:
V16.40 Genital organs, unspecified
V16.42 Prostate
V16.43 Testis
V16.59 Other
V16.8 Family history of malignant neoplasm
of male breast
V18.19 Family history of other endocrine and
metabolic disorders
V25.2 Encounter for contraceptive
management: sterilization (admission for
interruption of vas deferens)
V25.8 Encounter for contraceptive
management: other specified contraceptive
management (postvasectomy sperm count)
Procreative management:
V26.0 Vasoplasty after previous sterilization
Procreative management - Investigation and
testing:
V26.21 Fertility testing (sperm count)
V26.22 Aftercare following sterilization
reversal (sperm count following sterilization
reversal)
Procreative management - Genetic
counseling and testing:
V26.34 Testing of male for genetic disease
carrier status
V26.35 Testing of male partner of female
with recurrent pregnancy loss
V26.39 Other genetic testing of male
V26.33 Genetic counseling
Procreative management - General
counseling and advice:
V26.41 Procreative counseling and advice
using natural family planning
V26.42 Encounter for fertility preservation
Family history of malignant neoplasm of
genital organs:
N/A
Z80.42 Prostate
Z80.43 Testis
Z80.49 Other genital organs
Z80.8 Family history of malignant neoplasm
or other organs or systems
OR Z80.3 Family history of malignant
neoplasm of breast
Z83.49 Family history of other endocrine and
metabolic disorders
Z30.2 Encounter for contraceptive
management: sterilization
Z30.8 Encounter for other contraceptive
management: postvasectomy sperm count
Encounter for procreative management:
Z31.0 Reversal of previous sterilization
Encounter for procreative management Procreative investigation and testing:
Z31.41 Fertility testing (sperm count)
Z31.42 Aftercare following sterilization
reversal (sperm count following sterilization
reversal)
Encounter for genetic testing of male for
procreative management:
Z31.440 Encounter of male for testing for
genetic disease carrier status for procreative
management
Z31.441 Encounter for testing of male
partner patient with recurrent pregnancy
loss
Z31.448 Encounter for other genetic testing
of male for procreative management
Z31.5 Encounter for genetic counseling
Encounter for general counseling and advice
on procreation:
Z31.61 Procreative counseling and advice
using natural family planning
Z31.62 Encounter for fertility preservation
All information is subject to change. This is not an all-inclusive list.
counseling (prior to cancer therapy, prior
surgical removal of gonads)
V26.49 Other procreative management
counseling and advice
Procreative management – sterilization
status:
V26.52 Vasectomy
Procreative management – Other specified
procreative management
V26.82 Encounter for fertility preservation
procedure (prior to cancer therapy, prior to
surgical removal of gonads)
V26.89 Other specified procreative
management
V58.65 Long-term (current) use of steroids
V58.69 Long-term (current) use of other
medications: methadone for pain control,
opiate analgesics, other high-risk
medications)
V76.44 Special screening for malignant
neoplasm: prostate
V76.45 Special screening for malignant
neoplasm: testis
V77.99 Other & unspecified screening for
nutritional, metabolic, and immunity
disorders
V84.03 Genetic susceptibility to malignant
neoplasm of prostate
N/A
N/A
N/A
counseling (prior to cancer therapy, prior to
surgical removal of gonads)
Z31.69 Other general counseling and advice
on procreation
Other postprocedural states – sterilization
status:
Z98.52 Vasectomy
Encounter for other procreative
management:
Z31.84 Encounter for fertility preservation
procedure (prior to cancer therapy, prior to
surgical removal of gonads)
Z31.89 Encounter for other procreative
management
Z79.51 Long-term (current) use of inhaled
steroids
Z79.52 Long-term (current) use of systemic
steroids
Z79.891 Long-term (current) use of opiate
analgesic
Z12.5 Encounter for screening for malignant
neoplasm of prostate
Z12.71 Encounter for screening for malignant
neoplasm of testis
Z13.29 Encounter for screening other
suspected endocrine disorder
Z15.03 Genetic susceptibility to malignant
neoplasm of prostate
Z91.120 Patient’s intentional underdosing of
medication regimen due to financial hardship
(code first underdosing of medication [T36T50] with fifth or sixth character of 6)
Z91.128 Patient’s intentional underdosing of
medication regimen for other reason (code
first underdosing of medication [T36-T50]
with fifth or sixth character of 6)
Z91.130 Patient’s unintentional underdosing
of medication regimen due to age-related
debility (code first underdosing of medication
[T36-T50] with fifth or sixth character of 6)
All information is subject to change. This is not an all-inclusive list.
N/A
N/A
N/A
Z91.138 Patient’s unintentional underdosing
of medication regimen for other reason
(code first underdosing of medication [T36T50] with fifth or sixth character of 6)
Z91.14 Patient’s other noncompliance with
medication regimen (patient’s underdosing
of medication NOS) (code first underdosing
of medication [T36-T50] with fifth or sixth
character of 6)
Z91.19 Patient’s noncompliance with other
medical treatment and regimen
All information is subject to change. This is not an all-inclusive list.